As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education and atypical infections.
|Videos|September 12, 2016
Melanoma Survivors Encourage Others to Protect Their Skin
Author(s)Melanoma Foundation of New England
Advertisement
Melanoma is the second most common form of cancer for young people ages 15-29. It is a disease that affects a younger population. But the good news is: it’s preventable. By taking proper precautions and checking yourself monthly, you can protect yourself against melanoma.
Hear young survivors share their stories of survival.
Advertisement
Related to this article
Nicole Doell, MSN, RN, of Sylvester explains how nurses can address breast cancer misinformation without judgment and share vetted resources.
A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points nurses need for each.
Oral vitamin C did not slow clonal growth in the phase 2 EVITA trial but was linked to longer survival.
Sylvester's Nicole Doell, MSN, RN, discusses how oncology nurses can support patients with breast cancer emotionally, from diagnosis to survivorship.
Kathryn Shady, PhD, RN, OCN, discusses research on emotional dissonance and vicarious trauma among hematology/oncology nurses.
Daraxonrasib, tarlatamab, an mRNA melanoma therapy and ivonescimab led ESMO 2026. Tell us which findings you can act on now.
At an Oncology Nursing News roundtable, APPs discussed earlier lifileucel referral, IL-2 dosing, and toxicities that emerge after discharge.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Education, Infection Vigilance Define Outpatient Bispecific Care
2
October 2026 FDA Approvals: 7 Cancer Updates for Oncology Nurses
3
What Nurses Should Tell Patients About Vitamin C in CCUS and MDS
4
ESMO 2026 Poll: Which New Data Will Change Your Practice First?
5